 Safety pharmacokinetics functional activity human anti-Pseudomonas aeruginosa monoclonal antibodies septic nonseptic patients mixture IgM human monoclonal antibodies MAbs lipopolysaccharide antigens Pseudomonas aeruginosa human MAb exotoxin noninfected patients patients bacteremia pneumonia preparation dose range ml/kg mg/kg IgM protein single infusion ml/kg mg/kg IgM protein serum antibody titers therapeutic range serum half-lives opsonophagocytic activity serum antibody patient immunologic response MAb preparation